Skip to the content
Altai Oncology - Softwarelogo darklogo light
  • Library
  • Articles
  • Patient Education
  • F.A.Q.
  • Contact Us
Altai Oncology - Softwarelogo darklogo light
New Indication: Adjuvant Atezolizumab for ctDNA-Positive Bladder Cancer
Altai Protocol Library

New Indication: Adjuvant Atezolizumab for ctDNA-Positive Bladder Cancer

U. Darda Bayraktar, MD
2025-11-14
New Drug: Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
Altai Protocol Library

New Drug: Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer

U. Darda Bayraktar, MD
2025-11-13
New Reference: Neoadjuvant Carboplatin for Triple-Negative Breast Cancer
Altai Protocol Library

New Reference: Neoadjuvant Carboplatin for Triple-Negative Breast Cancer

U. Darda Bayraktar, MD
2025-11-13
New Reference: Nirogacestat for Desmoid Tumors
Altai Protocol Library

New Reference: Nirogacestat for Desmoid Tumors

U. Darda Bayraktar, MD
2025-11-13
New Reference: Darolutamide for Non-Metastatic Castration Resistant Prostate Cancer
Altai Protocol Library

New Reference: Darolutamide for Non-Metastatic Castration Resistant Prostate Cancer

U. Darda Bayraktar, MD
2025-11-13
New Reference: Pazopanib for Extrapancreatic Neuroendocrine Tumors
Altai Protocol Library

New Reference: Pazopanib for Extrapancreatic Neuroendocrine Tumors

U. Darda Bayraktar, MD
2025-11-13
New Reference: Lenvatinib - Everolimus for Metastatic Clear Cell RCC
Altai Protocol Library

New Reference: Lenvatinib – Everolimus for Metastatic Clear Cell RCC

U. Darda Bayraktar, MD
2025-11-12
New Reference: Enzalutamide in Biochemically Recurrent Prostate Cancer
Altai Protocol Library

New Reference: Enzalutamide in Biochemically Recurrent Prostate Cancer

U. Darda Bayraktar, MD
2025-11-12
New Reference: Revumenib for Rel/Ref KMT2A-Rearranged AML
Altai Protocol Library

New Reference: Revumenib for Rel/Ref KMT2A-Rearranged AML

U. Darda Bayraktar, MD
2025-11-06
New Reference: Belantamab for Multiple Myeloma
Altai Protocol Library

New Reference: Belantamab for Multiple Myeloma

U. Darda Bayraktar, MD
2025-11-06

Posts pagination

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
  • Library
  • F.A.Q.
  • Contact Us

Privacy Policy

Altai, Inc (USA)

30 N Gould St, Ste 6801

Sheridan, WY, 82801, USA

Phone: +1 (978) 393 0042

Altay Tıp Sağlık Yazılım AŞ (Türkiye)

Mutlukent Mah Manuk Bey Sk No: 4

Çankaya, Ankara, 06800, Türkiye

Phone: +90 (312) 911 5735

Our Terms & Privacy Policy

Copyright - 2024 - Altai Inc - All rights reserved

Back to top Drag
  • Library
  • Articles
  • Patient Education
  • F.A.Q.
  • Contact Us

jghghjghjghhgj